Department of Urology, Health Services Research Group, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA.
Urol Oncol. 2012 Jan-Feb;30(1):102-8. doi: 10.1016/j.urolonc.2011.09.001. Epub 2011 Nov 27.
Since 2001, UCLA has operated
Improving Access, Counseling, and Treatment for Californians with Prostate Cancer (CaP). Funded by the California Department of Public Health, with a cumulative budget of over $80 million, the program provides comprehensive care for low-income, uninsured Californian men with biopsy-proven CaP. Health services research conducted with program enrollees, through the UCLA Men's Health Study, yields an opportunity to perform qualitative and quantitative assessments of patient-reported outcomes in these men, all members of historically underserved, primarily minority populations. This review summarizes data from several studies in which validated instruments were administered longitudinally in 727 participants, prospectively measuring health-related quality of life (HRQOL), self-efficacy in interactions with physician interactions, social and emotional health, symptom distress, satisfaction with care, and other patient-reported outcomes.
自 2001 年以来，加州大学洛杉矶分校（UCLA）一直运营着 IMPACT：改善加利福尼亚前列腺癌（CaP）患者的获得途径、咨询和治疗。该项目由加利福尼亚州公共卫生部资助，累计预算超过 8000 万美元，为经活检证实患有 CaP 的低收入、 uninsured 加利福尼亚男性提供全面的护理。通过加州大学洛杉矶分校男性健康研究（UCLA Men's Health Study）对项目参与者进行的健康服务研究，为对这些男性（均来自历史上服务不足的主要少数族裔群体）的患者报告结果进行定性和定量评估提供了机会。这篇综述总结了几项研究的数据，在这些研究中，727 名参与者接受了纵向验证工具的评估，前瞻性地测量了与健康相关的生活质量（HRQOL）、与医生互动的自我效能、社会和情感健康、症状困扰、护理满意度和其他患者报告的结果。
